Therapeutics aims to improve current obesity treatment, specifically to increase overall body weight loss and fat mass loss, but p ...
Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.
5h
Tribune Content Agency on MSNAsk the Doctors: GLP-1 Microdosing Is Experimental and UnauthorizedI’ m trying to lose the 18 pounds I have gained since the pandemic. It has been hard enough that I’ m wondering about Ozempic. I’ m also hearing about people doing Ozempic microdosing.
Excess weight can trigger chronic low-grade inflammation, which has been linked to increased risk for conditions such as heart disease and dementia. GLP-1s work by suppressing appetite and making ...
Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...
With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...
Dayforce adopted digital twin technology to help employees with diabetes, and it is now using the tech for weight management.
Longevity doctor reveals common Ozempic mistakes affecting adults over 50, including protein deficiency, mental health risks, and muscle loss. Learn proper usage.
1d
MedPage Today on MSNEndocrine Society's New President-Elect; Judge Stops Compounders; New GLP-1 BenefitsGLP-1 drugs were also linked with better graft and patient survival in kidney transplant recipients with type 2 diabetes.
Consolidated revenues increased 43% year-over-year to $64.3 million with telehealth revenue up 60%Adjusted EBITDA increased 78% to $9.0 ...
Intensive management of diabetes pays fewer dividends as patients age and raises the chances of hypoglycemia. But many people ...
How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results